Welcome to the UPF Digital Repository

Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

Show simple item record

dc.contributor.author Velasco Hernandez, Talia
dc.contributor.author Beneyto Calabuig, Sergi
dc.contributor.author Velten, Lars
dc.contributor.author Lorden, Patricia
dc.contributor.author Eyras Jiménez, Eduardo
dc.contributor.author Heyn, Holger
dc.contributor.author Menéndez, Pablo
dc.date.accessioned 2024-07-26T06:41:05Z
dc.date.available 2024-07-26T06:41:05Z
dc.date.issued 2024
dc.identifier.citation Velasco-Hernandez T, Trincado JL, Vinyoles M, Closa A, Martínez-Moreno A, Gutiérrez-Agüera F, et al. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Hemasphere. 2024 Feb 26;8(2):e45. DOI: 10.1002/hem3.45
dc.identifier.issn 2572-9241
dc.identifier.uri http://hdl.handle.net/10230/60848
dc.description.abstract Relapse remains a major challenge in the clinical management of acute myeloid leukemia (AML) and is driven by rare therapy-resistant leukemia stem cells (LSCs) that reside in specific bone marrow niches. Hypoxia signaling maintains cells in a quiescent and metabolically relaxed state, desensitizing them to chemotherapy. This suggests the hypothesis that hypoxia contributes to the chemoresistance of AML-LSCs and may represent a therapeutic target to sensitize AML-LSCs to chemotherapy. Here, we identify HIFhigh and HIFlow specific AML subgroups (inv(16)/t(8;21) and MLLr, respectively) and provide a comprehensive single-cell expression atlas of 119,000 AML cells and AML-LSCs in paired diagnostic-relapse samples from these molecular subgroups. The HIF/hypoxia pathway signature is attenuated in AML-LSCs compared with more differentiated AML cells but is more expressed than in healthy hematopoietic cells. Importantly, chemical inhibition of HIF cooperates with standard-of-care chemotherapy to impair AML growth and to substantially eliminate AML-LSCs in vitro and in vivo. These findings support the HIF pathway in the stem cell-driven drug resistance of AML and unravel avenues for combinatorial targeted and chemotherapy-based approaches to specifically eliminate AML-LSCs.
dc.description.sponsorship This research was also supported by the Spanish Ministry of Economy and Competitiveness (SAF2016-80481R, PID2019-108160RB-I00/AEI/10.13039/50110011033), “la Caixa” Foundation (LCF/PR/HR19/52160011), the Leo Messi Foundation, “Heroes hasta la médula” initiative, Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 00887) and ISCIII-RICORS within the Next Generation EU program (plan de recuperación, transformación y resiliencia) to PM and the Health Institute Carlos III (ISCIII/FEDER, PI20/00 822) to Clara Bueno.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartof Hemasphere. 2024 Feb 26;8(2):e45
dc.rights © 2024 The Authors. HemaSphere published by John Wiley & Sons Ltd. on behalf of European Hematology Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.other Leucèmia mieloide aguda
dc.title Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1002/hem3.45
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/SAF2016-80481R
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/PID2019-108160RB-I00
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking